Quest Diagnostics Incorporated (DGX) — Technical state
As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +3.5% vs the 50-day and +16.3% vs the 200-day average, 3.9% below the 52-week high and +45.6% off the 52-week low. Computed from daily closes. (as of 2026-11-03)
- Trend: Quest Diagnostics Incorporated trades 3.5% above its 50-day and 16.3% above its 200-day moving average. (as of 2026-11-03)
Quest Diagnostics runs clinical laboratories and patient service centres across the United States, processing blood, tissue and other samples for hospitals, doctors and insurers. It offers routine and advanced testing in areas such as cancer, infectious disease, drug monitoring and women's health, plus risk-assessment work for life insurers and IT tools that connect results to health systems.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the DGX overview. Research diary readings, not advice.
Trades +3.5% vs the 50-day and +16.3% vs the 200-day average, 3.9% below the 52-week high and +45.6% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+3.2%
- vs 50-day+3.5%
- vs 200-day+16.3%
- 52-week band3.9% off the high · +45.6% off the low
- Streak3 consecutive down sessions
- 50-day crossprice crossed up through the 50-day 9 sessions ago
- Stochastic%K 70.3 · %D 88.5
Continue: the DGX chart & overview · the signal board
FAQ · from the current data · as of 2026-11-03
Quick answers
What is the current Closelooknet signal on DGX?
Uptrend stack intact — Trades +3.5% vs the 50-day and +16.3% vs the 200-day average, 3.9% below the 52-week high and +45.6% off the 52-week low. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is DGX above its 50-day and 200-day moving averages?
As of 2026-11-03, Quest Diagnostics Incorporated trades +3.5% above its 50-day and +16.3% above its 200-day average, with the 20-day +3.2% away.
How far is DGX from its 52-week high?
3.9% below the 52-week high and 45.6% above the 52-week low, as of 2026-11-03.
Mentioned on Closelooknet
Where DGX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
101 and glossary
- Sovereign AI: The National Compute Arms Race and Its Investment Map
The investment implications span from NVIDIA (selling DGX Cloud to governments globally) to Nebius (Yandex spin-off building European sovereign cloud) to Dell and HPE (on-premises AI infrastructure for nations with data residency…
Related in the Closelooknet universe
then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- MEDP Medpace Holdings Incindustry
- IDXX IDEXX Laboratories Incindustry
- ILMN Illumina Incindustry
- ICLR ICON PLCindustry
- GH Guardant Health Incindustry
- NTRA Natera Incindustry
- CDNA CareDx Incindustry
- GRAL GRAIL, LLCindustry
- CRL Charles River Laboratoriesindustry
- MTD Mettler-Toledo International Incindustry
- VCYT Veracyte Incindustry
- RVTY Revvity Inc.industry
- QGEN Qiagen NVindustry
- LH Labcorp Holdings Inc.industry
- OPK Opko Health Incindustry
- A Agilent Technologies Incindustry
- WAT Waters Corporationindustry
- TMO Thermo Fisher Scientific Incindustry
- BLLN BillionToOne, Inc. Class A Common Stockindustry
- DHR Danaher Corporationindustry